The rise of the CRO
Dr Chris Doherty discusses the rise of clinical research organisations (CROs) from his vantage point as managing director at Alderley Park
Search Results for: Dr Chris Doherty
Unlocking sci-tech growth in the UK
The health of the life sciences sector in 2019 will continue to be a major focus as the UK navigates all the issues surrounding Brexit.
Read More
Bruntwood to make £10M life science investment
Bruntwood SciTech has announced a £10 million investment into the life sciences sector, in the form of 50,000 square feet of office space and laboratory facilities in Alderley Park, Cheshire.
Read More
Ecosystems – the new networks of global innovation
Great science is increasingly the product of a web of interdependent enterprises and relationships functioning together to create value
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
